Name: Kovács Árpád
Degree
- PhD, Debreceni Egyetem (2019)
Publication list
2024
Kovács, Á.,
Zhazykbayeva, S.,
Herwig, M.,
Fülöp, G.,
Csípő, T.,
Oláh, N.,
Hassoun, R.,
Budde, H.,
Osman, H.,
Kaçmaz, M.,
Jaquet, K.,
Priksz, D.,
Juhász, B.,
Akin, I.,
Papp, Z.,
Schmidt, W.,
Mügge, A.,
El-Battrawy, I.,
Tóth, A.,
Hamdani, N.:
Sex-specific cardiovascular remodeling leads to a divergent sex-dependent development of heart failure in aged hypertensive rats.
GeroScience. [Epub ahead of print]2024.
Journal metrics:
Q1 Aging (2023)
Q1 Cardiology and Cardiovascular Medicine (2023)
D1 Complementary and Alternative Medicine (2023)
Q1 Geriatrics and Gerontology (2023)
D1 Veterinary (miscellaneous) (2023)
2023
Zhazykbayeva, S.,
Hassoun, R.,
Herwig, M.,
Budde, H.,
Kovács, Á.,
Mannherz, H.,
El-Battrawy, I.,
Tóth, A.,
Schmidt, W.,
Mügge, A.,
Hamdani, N.:
Oxidative stress and inflammation distinctly drive molecular mechanisms of diastolic dysfunction and remodeling in female and male heart failure with preserved ejection fraction rats.
Front. Cardiovasc. Med. 10 1-14, 2023.
Journal metrics:
Q2 Cardiology and Cardiovascular Medicine
Kovács, Á.,
Barta, J.:
Renin-Angiotensin-Aldosterone System as an Old New Target in Heart Failure Therapy: RAAS Inhibition in Heart Failure.
In: The Renin Angiotensin System in Cardiovascular Disease. Eds.: Naranjan S. Dhalla, Sukhwinder K. Bhullar, Anureet K. Shah, Springer, New York, 307-330, 2023, (Advances in Biochemistry in Health and Disease, ISSN 2512-2142 ; 24)
2022
Gömöri, K.,
Herwig, M.,
Hassoun, R.,
Budde, H.,
Mostafi, N.,
Delalat, S.,
Modi, S.,
Begovic, M.,
Szabados, T.,
Pipis, J.,
Farkas-Morvay, N.,
Leprán, I.,
Kovács, Á.,
Mügge, A.,
Ferdinándy, P.,
Görbe, A.,
Bencsik, P.,
Hamdani, N.:
Altered Cellular Protein Quality Control System Modulates Cardiomyocyte Function in Volume Overload-Induced Hypertrophy.
Antioxidants. 11 (11), 1-16, 2022.
Journal metrics:
Q1 Biochemistry
Q2 Cell Biology
Q1 Clinical Biochemistry
D1 Food Science
Q2 Molecular Biology
Q1 Physiology
Gömöri, K.,
Herwig, M.,
Budde, H.,
Hassoun, R.,
Mostafi, N.,
Zhazykbayeva, S.,
Sieme, M.,
Modi, S.,
Szabados, T.,
Pipis, J.,
Farkas-Morvay, N.,
Leprán, I.,
Ágoston, G.,
Baczkó, I.,
Kovács, Á.,
Mügge, A.,
Ferdinándy, P.,
Görbe, A.,
Bencsik, P.,
Hamdani, N.:
Ca2+/calmodulin-dependent protein kinase II and protein kinase G oxidation contributes to impaired sarcomeric proteins in hypertrophy model.
ESC Heart Failure. 9 (4), 2585-2600, 2022.
Journal metrics:
Q1 Cardiology and Cardiovascular Medicine
Budde, H.,
Hassoun, R.,
Mügge, A.,
Kovács, Á.,
Hamdani, N.:
Current Understanding of Molecular Pathophysiology of Heart Failure With Preserved Ejection Fraction.
Front. Physiol. 13 1-18, 2022.
Journal metrics:
Q2 Physiology
Q1 Physiology (medical)
Hassoun, R.,
Budde, H.,
Zhazykbayeva, S.,
Herwig, M.,
Sieme, M.,
Delalat, S.,
Mostafi, N.,
Gömöri, K.,
Tangos, M.,
Jarkas, M.,
Pabel, S.,
Bruckmüller, S.,
Skrygan, M.,
Lódi, M.,
Jaquet, K.,
Sequeira, V.,
Gambichler, T.,
Remedios, C.,
Kovács, Á.,
Mannherz, H.,
Mügge, A.,
Sossalla, S.,
Hamdani, N.:
Do they come together? Protein quality control, stress-activated signaling, and "sarcostat" in hypertrophic cardiomyopathy progression.
Int. J. Cardiol. 347 44-45, 2022.
Priksz, D.,
Lampé, N.,
Kovács, Á.,
Herwig, M.,
Bombicz, M.,
Varga, B.,
Wilisicz, T.,
Szilvássy, J.,
Pósa, A.,
Kiss, R.,
Gesztelyi, R.,
Ráduly, A.,
Szekeres, R.,
Sieme, M.,
Papp, Z.,
Tóth, A.,
Hamdani, N.,
Szilvássy, Z.,
Juhász, B.:
Nicotinic-acid derivative BGP-15 improves diastolic function in a rabbit model of atherosclerotic cardiomyopathy.
Br. J. Pharmacol. 179 (10), 2240-2258, 2022.
Tangos, M.,
Budde, H.,
Kolijn, D.,
Sieme, M.,
Zhazykbayeva, S.,
Lódi, M.,
Herwig, M.,
Gömöri, K.,
Hassoun, R.,
Robinson, E.,
Meister, T.,
Jaquet, K.,
Kovács, Á.,
Mustroph, J.,
Evert, K.,
Babel, N.,
Fagyas, M.,
Lindner, D.,
Püschel, K.,
Westermann, D.,
Mannherz, H.,
Paneni, F.,
Pfaender, S.,
Tóth, A.,
Mügge, A.,
Sossalla, S.,
Hamdani, N.:
SARS-CoV-2 infects human cardiac myocytes promoted by inflammation and oxidative stress.
Int. J. Cardiol. 362 196-205, 2022.
Journal metrics:
Q1 Cardiology and Cardiovascular Medicine
2021
Fagyas, M.,
Bánhegyi, V.,
Úri, K.,
Enyedi, A.,
Lizanecz, E.,
Mányiné Siket, I.,
Mártha, L.,
Fülöp, G.,
Radovits, T.,
Pólos, M.,
Merkely, B.,
Kovács, Á.,
Szilvássy, Z.,
Ungvári, Z.,
Édes, I.,
Csanádi, Z.,
Boczán, J.,
Takács, I.,
Szabó, G.,
Balla, J.,
Balla, G.,
Seferović, P.,
Papp, Z.,
Tóth, A.:
Changes in the SARS-CoV-2 cellular receptor ACE2 levels in cardiovascular patients: a potential biomarker for the stratification of COVID-19 patients.
GeroScience. 43 (5), 2289-2304, 2021.
Journal metrics:
D1 Aging
Q1 Cardiology and Cardiovascular Medicine
D1 Complementary and Alternative Medicine
D1 Geriatrics and Gerontology
D1 Veterinary (miscellaneous)
Kolijn, D.,
Pabel, S.,
Tian, Y.,
Lódi, M.,
Herwig, M.,
Carrizzo, A.,
Zhazykbayeva, S.,
Kovács, Á.,
Fülöp, G.,
Falcao-Pires, I.,
Reusch, P.,
Linthout, S.,
Papp, Z.,
Heerebeek, L.,
Vecchione, C.,
Maier, L.,
Ciccarelli, M.,
Tschöpe, C.,
Mügge, A.,
Bagi, Z.,
Sossalla, S.,
Hamdani, N.:
Empagliflozin Improves Endothelial and Cardiomyocyte Function in Human Heart Failure With Preserved Ejection Fraction via Reduced Pro-Inflammatory-Oxidative Pathways and Protein Kinase Gα Oxidation.
Cardiovasc. Res. 117 (2), 495-507, 2021.
Journal metrics:
D1 Cardiology and Cardiovascular Medicine
D1 Physiology
D1 Physiology (medical)
Pappritz, K.,
Dong, F.,
Miteva, K.,
Kovács, Á.,
El-Shafeey, M.,
Kerim, B.,
O'Flynn, L.,
Elliman, S.,
O'Brien, T.,
Hamdani, N.,
Tschöpe, C.,
Linthout, S.:
Impact of Syndecan-2-Selected Mesenchymal Stromal Cells on the Early Onset of Diabetic Cardiomyopathy in Diabetic db/db Mice.
Front. Cardiovasc. Med. 8 1-13, 2021.
Journal metrics:
Q1 Cardiology and Cardiovascular Medicine
Kovács, Á.,
Herwig, M.,
Budde, H.,
Delalat, S.,
Kolijn, D.,
Bódi, B.,
Hassoun, R.,
Tangos, M.,
Zhazykbayeva, S.,
Balogh, Á.,
Czuriga, D.,
Linthout, S.,
Tschöpe, C.,
Dhalla, N.,
Mügge, A.,
Tóth, A.,
Papp, Z.,
Barta, J.,
Hamdani, N.:
Interventricular Differences of Signaling Pathways-Mediated Regulation of Cardiomyocyte Function in Response to High Oxidative Stress in the Post-Ischemic Failing Rat Heart.
Antioxidants. 10 (6), 1-21, 2021.
Journal metrics:
Q2 Biochemistry
Q2 Cell Biology
Q1 Clinical Biochemistry
Q2 Molecular Biology
Q2 Physiology
Bódi, B.,
Kovács, Á.,
Gulyás, H.,
Mártha, L.,
Tóth, A.,
Mátyás, C.,
Barta, B.,
Oláh, A.,
Merkely, B.,
Radovits, T.,
Papp, Z.:
Long-Term PDE-5A Inhibition Improves Myofilament Function in Left and Right Ventricular Cardiomyocytes through Partially Different Mechanisms in Diabetic Rat Hearts.
Antioxidants. 10 (11), 1-13, 2021.
Journal metrics:
Q2 Biochemistry
Q2 Cell Biology
Q1 Clinical Biochemistry
Q2 Molecular Biology
Q2 Physiology
Pappritz, K.,
Klein, O.,
Dong, F.,
Hamdani, N.,
Kovács, Á.,
O'Flynn, L.,
Elliman, S.,
O'Brien, T.,
Tschöpe, C.,
Linthout, S.:
MALDI-IMS as a Tool to Determine the Myocardial Response to Syndecan-2-Selected Mesenchymal Stromal Cell Application in an Experimental Model of Diabetic Cardiomyopathy.
Proteom. Clin. Appl. 15 (1), 1-10, 2021.
Fülöp, G.,
Oláh, A.,
Csípő, T.,
Kovács, Á.,
Pórszász, R.,
Veress, R.,
Horváth, B.,
Nagy, L.,
Bódi, B.,
Fagyas, M.,
Helgadottir, S.,
Bánhegyi, V.,
Juhász, B.,
Bombicz, M.,
Priksz, D.,
Nánási, P.,
Merkely, B.,
Édes, I.,
Csanádi, Z.,
Papp, Z.,
Radovits, T.,
Tóth, A.:
Omecamtiv mecarbil evokes diastolic dysfunction and leads to periodic electromechanical alternans.
Basic Res. Cardiol. 116 (1), 24, 2021.
Journal metrics:
Q1 Cardiology and Cardiovascular Medicine
Q1 Physiology
Q1 Physiology (medical)
Hassoun, R.,
Budde, H.,
Zhazykbayeva, S.,
Herwig, M.,
Sieme, M.,
Delalat, S.,
Mostafi, N.,
Gömöri, K.,
Tangos, M.,
Jarkas, M.,
Pabel, S.,
Bruckmüller, S.,
Skrygan, M.,
Lódi, M.,
Jaquet, K.,
Sequeira, V.,
Gambichler, T.,
Remedios, C.,
Kovács, Á.,
Mannherz, H.,
Mügge, A.,
Sossalla, S.,
Hamdani, N.:
Stress activated signalling impaired protein quality control pathways in human hypertrophic cardiomyopathy.
Int. J. Cardiol. 344 160-169, 2021.
Journal metrics:
Q1 Cardiology and Cardiovascular Medicine
Budde, H.,
Hassoun, R.,
Tangos, M.,
Zhazykbayeva, S.,
Herwig, M.,
Varatnitskaya, M.,
Sieme, M.,
Delalat, S.,
Sultana, I.,
Kolijn, D.,
Gömöri, K.,
Jarkas, M.,
Lódi, M.,
Jaquet, K.,
Kovács, Á.,
Mannherz, H.,
Sequeira, V.,
Mügge, A.,
Leichert, L.,
Sossalla, S.,
Hamdani, N.:
The Interplay between S-Glutathionylation and Phosphorylation of Cardiac Troponin I and Myosin Binding Protein C in End-Stage Human Failing Hearts.
Antioxidants. 10 (7), 1-26, 2021.
Journal metrics:
Q2 Biochemistry
Q2 Cell Biology
Q1 Clinical Biochemistry
Q2 Molecular Biology
Q2 Physiology
2020
Reil, J.,
Reil, G.,
Kovács, Á.,
Sequeira, V.,
Waddingham, M.,
Lódi, M.,
Herwig, M.,
Ghaderi, S.,
Kreusser, M.,
Papp, Z.,
Voigt, N.,
Dobrev, D.,
Meyhöfer, S.,
Langer, H.,
Maier, L.,
Linz, D.,
Mügge, A.,
Hohl, M.,
Steendijk, P.,
Hamdani, N.:
CaMKII Activity Contributes to Homeometric Autoregulation of the Heart: a Novel Mechanism for the Anrep Effect.
J. Physiol.-London. 598 (15), 3129-3153, 2020.
Journal metrics:
Q1 Physiology
D1 Sports Science
Kolijn, D.,
Kovács, Á.,
Herwig, M.,
Lódi, M.,
Sieme, M.,
Alhaj, A.,
Sandner, P.,
Papp, Z.,
Reusch, P.,
Haldenwang, P.,
Falcao-Pires, I.,
Linke, W.,
Jaquet, K.,
Linthout, S.,
Mügge, A.,
Tschöpe, C.,
Hamdani, N.:
Enhanced Cardiomyocyte Function in Hypertensive Rats With Diastolic Dysfunction and Human Heart Failure Patients After Acute Treatment With Soluble Guanylyl Cyclase (sGC) Activator.
Front. Physiol. 11 1-21, 2020.
Journal metrics:
Q2 Physiology
Q2 Physiology (medical)
Herwig, M.,
Kolijn, D.,
Lódi, M.,
Hölper, S.,
Kovács, Á.,
Papp, Z.,
Jaquet, K.,
Haldenwang, P.,
Dos Remedios, C.,
Reusch, P.,
Mügge, A.,
Krüger, M.,
Fielitz, J.,
Linke, W.,
Hamdani, N.:
Modulation of Titin-Based Stiffness in Hypertrophic Cardiomyopathy via Protein Kinase D.
Front. Physiol. 11 240, 2020.
Journal metrics:
Q2 Physiology
Q2 Physiology (medical)
Lódi, M.,
Bánhegyi, V.,
Bódi, B.,
Gyöngyösi, A.,
Kovács, Á.,
Árokszállási, A.,
Hamdani, N.,
Fagyas, M.,
Édes, I.,
Csanádi, Z.,
Czuriga, I.,
Kisvárday, Z.,
Lekli, I.,
Bai, P.,
Tóth, A.,
Papp, Z.,
Czuriga, D.:
Prophylactic, single-drug cardioprotection in a comparative, experimental study of doxorubicin-induced cardiomyopathy.
J. Transl. Med. 18 (1), 470, 2020.
Journal metrics:
Q1 Biochemistry, Genetics and Molecular Biology (miscellaneous)
D1 Medicine (miscellaneous)
2019
Lódi, M.,
Priksz, D.,
Fülöp, G.,
Bódi, B.,
Gyöngyösi, A.,
Nagy, L.,
Kovács, Á.,
Kertész, A.,
Kocsis, J.,
Édes, I.,
Csanádi, Z.,
Czuriga, I.,
Kisvárday, Z.,
Juhász, B.,
Lekli, I.,
Bai, P.,
Tóth, A.,
Papp, Z.,
Czuriga, D.:
Advantages of prophylactic versus conventionally scheduled heart failure therapy in an experimental model of doxorubicin-induced cardiomyopathy.
J. Transl. Med. 17 229, 2019.
Journal metrics:
Q1 Biochemistry, Genetics and Molecular Biology (miscellaneous)
D1 Medicine (miscellaneous)
2018
Pabel, S.,
Wagner, S.,
Bollenberg, H.,
Bengel, P.,
Kovács, Á.,
Schach, C.,
Tirilomis, P.,
Mustroph, J.,
Renner, A.,
Gummert, J.,
Fischer, T.,
Linthout, S.,
Tschöpe, C.,
Streckfuss-Bömeke, K.,
Hasenfuß, G.,
Maier, L.,
Hamdani, N.,
Sossalla, S.:
Empagliflozin directly improves diastolic function in human heart failure.
Eur. J. Heart Fail. 20 (12), 1690-1700, 2018.
Journal metrics:
D1 Cardiology and Cardiovascular Medicine
2024
Kovács, Á.,
Zhazykbayeva, S.,
Herwig, M.,
Fülöp, G.,
Csípő, T.,
Oláh, N.,
Hassoun, R.,
Budde, H.,
Osman, H.,
Kaçmaz, M.,
Jaquet, K.,
Priksz, D.,
Juhász, B.,
Akin, I.,
Papp, Z.,
Schmidt, W.,
Mügge, A.,
El-Battrawy, I.,
Tóth, A.,
Hamdani, N.:
Sex-specific cardiovascular remodeling leads to a divergent sex-dependent development of heart failure in aged hypertensive rats.
GeroScience. [Epub ahead of print]2024.
Journal metrics:
Q1 Aging (2023)
Q1 Cardiology and Cardiovascular Medicine (2023)
D1 Complementary and Alternative Medicine (2023)
Q1 Geriatrics and Gerontology (2023)
D1 Veterinary (miscellaneous) (2023)
2023
Zhazykbayeva, S.,
Hassoun, R.,
Herwig, M.,
Budde, H.,
Kovács, Á.,
Mannherz, H.,
El-Battrawy, I.,
Tóth, A.,
Schmidt, W.,
Mügge, A.,
Hamdani, N.:
Oxidative stress and inflammation distinctly drive molecular mechanisms of diastolic dysfunction and remodeling in female and male heart failure with preserved ejection fraction rats.
Front. Cardiovasc. Med. 10 1-14, 2023.
Journal metrics:
Q2 Cardiology and Cardiovascular Medicine
Kovács, Á.,
Barta, J.:
Renin-Angiotensin-Aldosterone System as an Old New Target in Heart Failure Therapy: RAAS Inhibition in Heart Failure.
In: The Renin Angiotensin System in Cardiovascular Disease. Eds.: Naranjan S. Dhalla, Sukhwinder K. Bhullar, Anureet K. Shah, Springer, New York, 307-330, 2023, (Advances in Biochemistry in Health and Disease, ISSN 2512-2142 ; 24)
2022
Gömöri, K.,
Herwig, M.,
Hassoun, R.,
Budde, H.,
Mostafi, N.,
Delalat, S.,
Modi, S.,
Begovic, M.,
Szabados, T.,
Pipis, J.,
Farkas-Morvay, N.,
Leprán, I.,
Kovács, Á.,
Mügge, A.,
Ferdinándy, P.,
Görbe, A.,
Bencsik, P.,
Hamdani, N.:
Altered Cellular Protein Quality Control System Modulates Cardiomyocyte Function in Volume Overload-Induced Hypertrophy.
Antioxidants. 11 (11), 1-16, 2022.
Journal metrics:
Q1 Biochemistry
Q2 Cell Biology
Q1 Clinical Biochemistry
D1 Food Science
Q2 Molecular Biology
Q1 Physiology
Gömöri, K.,
Herwig, M.,
Budde, H.,
Hassoun, R.,
Mostafi, N.,
Zhazykbayeva, S.,
Sieme, M.,
Modi, S.,
Szabados, T.,
Pipis, J.,
Farkas-Morvay, N.,
Leprán, I.,
Ágoston, G.,
Baczkó, I.,
Kovács, Á.,
Mügge, A.,
Ferdinándy, P.,
Görbe, A.,
Bencsik, P.,
Hamdani, N.:
Ca2+/calmodulin-dependent protein kinase II and protein kinase G oxidation contributes to impaired sarcomeric proteins in hypertrophy model.
ESC Heart Failure. 9 (4), 2585-2600, 2022.
Journal metrics:
Q1 Cardiology and Cardiovascular Medicine
Budde, H.,
Hassoun, R.,
Mügge, A.,
Kovács, Á.,
Hamdani, N.:
Current Understanding of Molecular Pathophysiology of Heart Failure With Preserved Ejection Fraction.
Front. Physiol. 13 1-18, 2022.
Journal metrics:
Q2 Physiology
Q1 Physiology (medical)
Hassoun, R.,
Budde, H.,
Zhazykbayeva, S.,
Herwig, M.,
Sieme, M.,
Delalat, S.,
Mostafi, N.,
Gömöri, K.,
Tangos, M.,
Jarkas, M.,
Pabel, S.,
Bruckmüller, S.,
Skrygan, M.,
Lódi, M.,
Jaquet, K.,
Sequeira, V.,
Gambichler, T.,
Remedios, C.,
Kovács, Á.,
Mannherz, H.,
Mügge, A.,
Sossalla, S.,
Hamdani, N.:
Do they come together? Protein quality control, stress-activated signaling, and "sarcostat" in hypertrophic cardiomyopathy progression.
Int. J. Cardiol. 347 44-45, 2022.
Priksz, D.,
Lampé, N.,
Kovács, Á.,
Herwig, M.,
Bombicz, M.,
Varga, B.,
Wilisicz, T.,
Szilvássy, J.,
Pósa, A.,
Kiss, R.,
Gesztelyi, R.,
Ráduly, A.,
Szekeres, R.,
Sieme, M.,
Papp, Z.,
Tóth, A.,
Hamdani, N.,
Szilvássy, Z.,
Juhász, B.:
Nicotinic-acid derivative BGP-15 improves diastolic function in a rabbit model of atherosclerotic cardiomyopathy.
Br. J. Pharmacol. 179 (10), 2240-2258, 2022.
Tangos, M.,
Budde, H.,
Kolijn, D.,
Sieme, M.,
Zhazykbayeva, S.,
Lódi, M.,
Herwig, M.,
Gömöri, K.,
Hassoun, R.,
Robinson, E.,
Meister, T.,
Jaquet, K.,
Kovács, Á.,
Mustroph, J.,
Evert, K.,
Babel, N.,
Fagyas, M.,
Lindner, D.,
Püschel, K.,
Westermann, D.,
Mannherz, H.,
Paneni, F.,
Pfaender, S.,
Tóth, A.,
Mügge, A.,
Sossalla, S.,
Hamdani, N.:
SARS-CoV-2 infects human cardiac myocytes promoted by inflammation and oxidative stress.
Int. J. Cardiol. 362 196-205, 2022.
Journal metrics:
Q1 Cardiology and Cardiovascular Medicine
2021
Fagyas, M.,
Bánhegyi, V.,
Úri, K.,
Enyedi, A.,
Lizanecz, E.,
Mányiné Siket, I.,
Mártha, L.,
Fülöp, G.,
Radovits, T.,
Pólos, M.,
Merkely, B.,
Kovács, Á.,
Szilvássy, Z.,
Ungvári, Z.,
Édes, I.,
Csanádi, Z.,
Boczán, J.,
Takács, I.,
Szabó, G.,
Balla, J.,
Balla, G.,
Seferović, P.,
Papp, Z.,
Tóth, A.:
Changes in the SARS-CoV-2 cellular receptor ACE2 levels in cardiovascular patients: a potential biomarker for the stratification of COVID-19 patients.
GeroScience. 43 (5), 2289-2304, 2021.
Journal metrics:
D1 Aging
Q1 Cardiology and Cardiovascular Medicine
D1 Complementary and Alternative Medicine
D1 Geriatrics and Gerontology
D1 Veterinary (miscellaneous)
Kolijn, D.,
Pabel, S.,
Tian, Y.,
Lódi, M.,
Herwig, M.,
Carrizzo, A.,
Zhazykbayeva, S.,
Kovács, Á.,
Fülöp, G.,
Falcao-Pires, I.,
Reusch, P.,
Linthout, S.,
Papp, Z.,
Heerebeek, L.,
Vecchione, C.,
Maier, L.,
Ciccarelli, M.,
Tschöpe, C.,
Mügge, A.,
Bagi, Z.,
Sossalla, S.,
Hamdani, N.:
Empagliflozin Improves Endothelial and Cardiomyocyte Function in Human Heart Failure With Preserved Ejection Fraction via Reduced Pro-Inflammatory-Oxidative Pathways and Protein Kinase Gα Oxidation.
Cardiovasc. Res. 117 (2), 495-507, 2021.
Journal metrics:
D1 Cardiology and Cardiovascular Medicine
D1 Physiology
D1 Physiology (medical)
Pappritz, K.,
Dong, F.,
Miteva, K.,
Kovács, Á.,
El-Shafeey, M.,
Kerim, B.,
O'Flynn, L.,
Elliman, S.,
O'Brien, T.,
Hamdani, N.,
Tschöpe, C.,
Linthout, S.:
Impact of Syndecan-2-Selected Mesenchymal Stromal Cells on the Early Onset of Diabetic Cardiomyopathy in Diabetic db/db Mice.
Front. Cardiovasc. Med. 8 1-13, 2021.
Journal metrics:
Q1 Cardiology and Cardiovascular Medicine
Kovács, Á.,
Herwig, M.,
Budde, H.,
Delalat, S.,
Kolijn, D.,
Bódi, B.,
Hassoun, R.,
Tangos, M.,
Zhazykbayeva, S.,
Balogh, Á.,
Czuriga, D.,
Linthout, S.,
Tschöpe, C.,
Dhalla, N.,
Mügge, A.,
Tóth, A.,
Papp, Z.,
Barta, J.,
Hamdani, N.:
Interventricular Differences of Signaling Pathways-Mediated Regulation of Cardiomyocyte Function in Response to High Oxidative Stress in the Post-Ischemic Failing Rat Heart.
Antioxidants. 10 (6), 1-21, 2021.
Journal metrics:
Q2 Biochemistry
Q2 Cell Biology
Q1 Clinical Biochemistry
Q2 Molecular Biology
Q2 Physiology
Bódi, B.,
Kovács, Á.,
Gulyás, H.,
Mártha, L.,
Tóth, A.,
Mátyás, C.,
Barta, B.,
Oláh, A.,
Merkely, B.,
Radovits, T.,
Papp, Z.:
Long-Term PDE-5A Inhibition Improves Myofilament Function in Left and Right Ventricular Cardiomyocytes through Partially Different Mechanisms in Diabetic Rat Hearts.
Antioxidants. 10 (11), 1-13, 2021.
Journal metrics:
Q2 Biochemistry
Q2 Cell Biology
Q1 Clinical Biochemistry
Q2 Molecular Biology
Q2 Physiology
Pappritz, K.,
Klein, O.,
Dong, F.,
Hamdani, N.,
Kovács, Á.,
O'Flynn, L.,
Elliman, S.,
O'Brien, T.,
Tschöpe, C.,
Linthout, S.:
MALDI-IMS as a Tool to Determine the Myocardial Response to Syndecan-2-Selected Mesenchymal Stromal Cell Application in an Experimental Model of Diabetic Cardiomyopathy.
Proteom. Clin. Appl. 15 (1), 1-10, 2021.
Fülöp, G.,
Oláh, A.,
Csípő, T.,
Kovács, Á.,
Pórszász, R.,
Veress, R.,
Horváth, B.,
Nagy, L.,
Bódi, B.,
Fagyas, M.,
Helgadottir, S.,
Bánhegyi, V.,
Juhász, B.,
Bombicz, M.,
Priksz, D.,
Nánási, P.,
Merkely, B.,
Édes, I.,
Csanádi, Z.,
Papp, Z.,
Radovits, T.,
Tóth, A.:
Omecamtiv mecarbil evokes diastolic dysfunction and leads to periodic electromechanical alternans.
Basic Res. Cardiol. 116 (1), 24, 2021.
Journal metrics:
Q1 Cardiology and Cardiovascular Medicine
Q1 Physiology
Q1 Physiology (medical)
Hassoun, R.,
Budde, H.,
Zhazykbayeva, S.,
Herwig, M.,
Sieme, M.,
Delalat, S.,
Mostafi, N.,
Gömöri, K.,
Tangos, M.,
Jarkas, M.,
Pabel, S.,
Bruckmüller, S.,
Skrygan, M.,
Lódi, M.,
Jaquet, K.,
Sequeira, V.,
Gambichler, T.,
Remedios, C.,
Kovács, Á.,
Mannherz, H.,
Mügge, A.,
Sossalla, S.,
Hamdani, N.:
Stress activated signalling impaired protein quality control pathways in human hypertrophic cardiomyopathy.
Int. J. Cardiol. 344 160-169, 2021.
Journal metrics:
Q1 Cardiology and Cardiovascular Medicine
Budde, H.,
Hassoun, R.,
Tangos, M.,
Zhazykbayeva, S.,
Herwig, M.,
Varatnitskaya, M.,
Sieme, M.,
Delalat, S.,
Sultana, I.,
Kolijn, D.,
Gömöri, K.,
Jarkas, M.,
Lódi, M.,
Jaquet, K.,
Kovács, Á.,
Mannherz, H.,
Sequeira, V.,
Mügge, A.,
Leichert, L.,
Sossalla, S.,
Hamdani, N.:
The Interplay between S-Glutathionylation and Phosphorylation of Cardiac Troponin I and Myosin Binding Protein C in End-Stage Human Failing Hearts.
Antioxidants. 10 (7), 1-26, 2021.
Journal metrics:
Q2 Biochemistry
Q2 Cell Biology
Q1 Clinical Biochemistry
Q2 Molecular Biology
Q2 Physiology
2020
Reil, J.,
Reil, G.,
Kovács, Á.,
Sequeira, V.,
Waddingham, M.,
Lódi, M.,
Herwig, M.,
Ghaderi, S.,
Kreusser, M.,
Papp, Z.,
Voigt, N.,
Dobrev, D.,
Meyhöfer, S.,
Langer, H.,
Maier, L.,
Linz, D.,
Mügge, A.,
Hohl, M.,
Steendijk, P.,
Hamdani, N.:
CaMKII Activity Contributes to Homeometric Autoregulation of the Heart: a Novel Mechanism for the Anrep Effect.
J. Physiol.-London. 598 (15), 3129-3153, 2020.
Journal metrics:
Q1 Physiology
D1 Sports Science
Kolijn, D.,
Kovács, Á.,
Herwig, M.,
Lódi, M.,
Sieme, M.,
Alhaj, A.,
Sandner, P.,
Papp, Z.,
Reusch, P.,
Haldenwang, P.,
Falcao-Pires, I.,
Linke, W.,
Jaquet, K.,
Linthout, S.,
Mügge, A.,
Tschöpe, C.,
Hamdani, N.:
Enhanced Cardiomyocyte Function in Hypertensive Rats With Diastolic Dysfunction and Human Heart Failure Patients After Acute Treatment With Soluble Guanylyl Cyclase (sGC) Activator.
Front. Physiol. 11 1-21, 2020.
Journal metrics:
Q2 Physiology
Q2 Physiology (medical)
Herwig, M.,
Kolijn, D.,
Lódi, M.,
Hölper, S.,
Kovács, Á.,
Papp, Z.,
Jaquet, K.,
Haldenwang, P.,
Dos Remedios, C.,
Reusch, P.,
Mügge, A.,
Krüger, M.,
Fielitz, J.,
Linke, W.,
Hamdani, N.:
Modulation of Titin-Based Stiffness in Hypertrophic Cardiomyopathy via Protein Kinase D.
Front. Physiol. 11 240, 2020.
Journal metrics:
Q2 Physiology
Q2 Physiology (medical)
Lódi, M.,
Bánhegyi, V.,
Bódi, B.,
Gyöngyösi, A.,
Kovács, Á.,
Árokszállási, A.,
Hamdani, N.,
Fagyas, M.,
Édes, I.,
Csanádi, Z.,
Czuriga, I.,
Kisvárday, Z.,
Lekli, I.,
Bai, P.,
Tóth, A.,
Papp, Z.,
Czuriga, D.:
Prophylactic, single-drug cardioprotection in a comparative, experimental study of doxorubicin-induced cardiomyopathy.
J. Transl. Med. 18 (1), 470, 2020.
Journal metrics:
Q1 Biochemistry, Genetics and Molecular Biology (miscellaneous)
D1 Medicine (miscellaneous)
2019
Lódi, M.,
Priksz, D.,
Fülöp, G.,
Bódi, B.,
Gyöngyösi, A.,
Nagy, L.,
Kovács, Á.,
Kertész, A.,
Kocsis, J.,
Édes, I.,
Csanádi, Z.,
Czuriga, I.,
Kisvárday, Z.,
Juhász, B.,
Lekli, I.,
Bai, P.,
Tóth, A.,
Papp, Z.,
Czuriga, D.:
Advantages of prophylactic versus conventionally scheduled heart failure therapy in an experimental model of doxorubicin-induced cardiomyopathy.
J. Transl. Med. 17 229, 2019.
Journal metrics:
Q1 Biochemistry, Genetics and Molecular Biology (miscellaneous)
D1 Medicine (miscellaneous)
2018
Pabel, S.,
Wagner, S.,
Bollenberg, H.,
Bengel, P.,
Kovács, Á.,
Schach, C.,
Tirilomis, P.,
Mustroph, J.,
Renner, A.,
Gummert, J.,
Fischer, T.,
Linthout, S.,
Tschöpe, C.,
Streckfuss-Bömeke, K.,
Hasenfuß, G.,
Maier, L.,
Hamdani, N.,
Sossalla, S.:
Empagliflozin directly improves diastolic function in human heart failure.
Eur. J. Heart Fail. 20 (12), 1690-1700, 2018.
Journal metrics:
D1 Cardiology and Cardiovascular Medicine
2017
Nagy, L.,
Gődény, I.,
Nánási, P.,
Leskó, Á.,
Balogh, L.,
Bánhegyi, V.,
Bódi, B.,
Csípő, T.,
Csongrádi, A.,
Fülöp, G.,
Kovács, Á.,
Lódi, M.,
Papp, Z.:
A szív pozitív inotróp támogatása a miozin-aktivátor hatású omecamtiv-mecarbil segítségével.
Cardiol. Hung. 47 (1), 69-76, 2017.
Szokol, M.,
Priksz, D.,
Bombicz, M.,
Varga, B.,
Kovács, Á.,
Fülöp, G.,
Csípő, T.,
Pósa, A.,
Tóth, A.,
Papp, Z.,
Szilvássy, Z.,
Juhász, B.:
Long term osmotic mini pump treatment with alpha-MSH improves myocardial function in Zucker Diabetic Fatty rats.
Molecules. 22 (10), 1-18, 2017.
Journal metrics:
Q1 Analytical Chemistry
Q1 Chemistry (miscellaneous)
Q2 Drug Discovery
Q2 Medicine (miscellaneous)
Q3 Molecular Medicine
Q2 Organic Chemistry
Q1 Pharmaceutical Science
Q2 Physical and Theoretical Chemistry
Kovács, Á.,
Kalász, J.,
Pásztorné Tóth, E.,
Tóth, A.,
Papp, Z.,
Dhalla, N.,
Barta, J.:
Myosin heavy chain and cardiac troponin T damage is associated with impaired myofibrillar ATPase activity contributing to sarcomeric dysfunction in Ca2+-paradox rat hearts.
Mol. Cell. Biochem. 403 (1-2), 57-68, 2017.
Journal metrics:
Q3 Cell Biology
Q2 Clinical Biochemistry
Q1 Medicine (miscellaneous)
Q3 Molecular Biology
Bódi, B.,
Pásztorné Tóth, E.,
Nagy, L.,
Tóth, A.,
Mártha, L.,
Kovács, Á.,
Balla, G.,
Kovács, T.,
Papp, Z.:
Titin isoforms are increasingly protected against oxidative modifications in developing rat cardiomyocytes.
Free Radic. Biol. Med. 113 224-235, 2017.
Journal metrics:
Q1 Biochemistry
Q1 Physiology (medical)
2016
Kovács, Á.,
Fülöp, G.,
Kovács, A.,
Csípő, T.,
Bódi, B.,
Priksz, D.,
Juhász, B.,
Beke, L.,
Hendrik, Z.,
Méhes, G.,
Granzier, H.,
Édes, I.,
Fagyas, M.,
Papp, Z.,
Barta, J.,
Tóth, A.:
Renin overexpression leads to increased titin-based stiffness contributing to diastolic dysfunction in hypertensive mRen2 rats.
Am. J. Physiol.-Heart Circul. Physiol. 310 (11), H1671-H1682, 2016.
Journal metrics:
Q1 Cardiology and Cardiovascular Medicine
Q1 Physiology
Q1 Physiology (medical)
2015
Nagy, L.,
Kovács, Á.,
Bódi, B.,
Pásztorné Tóth, E.,
Fülöp, G.,
Tóth, A.,
Édes, I.,
Papp, Z.:
The novel cardiac myosin activator omecamtiv mecarbil increases the calcium sensitivity of force production in isolated cardiomyocytes and skeletal muscle fibres of the rat.
Br. J. Pharmacol. 172 (18), 4506-4518, 2015.
2014
Balogh, Á.,
Tóth, A.,
Pásztorné Tóth, E.,
Nagy, L.,
Kovács, Á.,
Kalász, J.,
Contreras, G.,
Édes, I.,
Papp, Z.:
Myofilament carbonylation modulates contractility in human cardiomyocytes.
Exp. Clin. Cardiol. 20 (1), 2026-2035, 2014.
Journal metrics:
Q3 Cardiology and Cardiovascular Medicine
Q4 Physiology
Q3 Physiology (medical)
Show all
updated: 2024-10-06, 02:32